Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
Study Identifier:
C07-002
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: eculizumab
Date
Sep 2007 - Sep 2008
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years
Requirements Information
Sex
Female & Male
Age
18+ years
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: eculizumab
Date
Sep 2007 - Sep 2008
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years years
Requirements Information
Protocol Summary
This study is to designed to test the role of complement in the late asthmatic response to allergen challenge in mild asthma, as an indicator of the possible role of complement in the broader asthmatic population.
Trial Locations
Location
Status
Location
McMaster University
Hamilton, Ontario, Canada, L8N 3Z5
Status
N/A
Location
Hospital Laval
Ste-Foy, Quebec, Canada, G1V 4G5
Status
N/A